William Blair starts coverage on Compass Therapeutics, saying its lead drug could reshape bile duct cancer treatment and ...

Gallbladder cancer is a rare and often aggressive malignancy that develops in the tissues of the gallbladder — a small, ...

Certain foods can exacerbate symptoms of bile duct cancer. People may find relief by avoiding those foods, such as processed foods. A dietitian can also help create an appropriate eating plan. The ...

Bile duct cancer can often be treated more effectively when detected early. However, its initial symptoms are often mild and can resemble common digestive or liver problems, leading to delayed ...

About 8,000 people are diagnosed with bile duct cancer each year. But the actual number of cases is likely to be higher, because these cancers can be hard to diagnose, and some might be misclassified ...

Bile duct cancer, or cholangiocarcinoma, is a rare type of cancer that starts in the bile ducts. Bile ducts are small tubes in your body that carry bile (digestive fluids) from your liver and ...

Please provide your email address to receive an email when new articles are posted on . Researchers reported a 41% confirmed ORR among patients with HER2-positive disease. No patients with ...

The FDA approved Imfinzi with gemcitabine and cisplatin for advanced biliary tract cancer based on the TOPAZ-1 trial results. The trial showed improved overall survival of 12.8 months with Imfinzi ...

NEW YORK (Reuters Health) - The results of a study published in the International Journal of Cancer suggest there is an association between hepatitis B virus (HBV) infection and an increased risk of ...

Use of pathological response versus RECIST assessment in predicting relapse-free survival following neoadjuvant immunotherapy for hepatocellular carcinoma. Expanded biomarker analysis of an ...

Approval of the Taiho drug, futibatinib, covers adults with intrahepatic cholangiocarcinoma, a rare cancer affecting the bile ducts of the liver. Many genetic variants can drive the progression of ...